Life after SOLO-2: is olaparib really inducing platinum resistance in BRCA-mutated (BRCAm), PARP inhibitor (PARPi)-resistant, recurrent ovarian cancer?

R.S. Kristeleit & K.N. Moore · 2022-08-12

Authors
R.S. Kristeleit, K.N. Moore